The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus-associated disease in breakthrough infections in adults ≥60 years of age
呼吸道合胞病毒融合前F蛋白疫苗可减轻60岁及以上成年人突破性感染中呼吸道合胞病毒相关疾病的严重程度。
期刊:Influenza and Other Respiratory Viruses
影响因子:4.2
doi:10.1111/irv.13236
Curran, Desmond; Matthews, Sean; Cabrera, Eliazar Sabater; Pérez, Silvia Narejos; Breva, Lina Pérez; Rämet, Mika; Helman, Laura; Park, Dae Won; Schwarz, Tino F; Melendez, Isabel Maria Galan; Schaefer, Axel; Roy, Nathalie; Stephan, Brigitte; Molnar, Daniel; Kostanyan, Lusine; Powers, John H 3rd; Hulstrøm, Veronica
